Skip to content
NYSE: IGC
|
Borse Berlin: IGS1.BE
|
Frankfurt: IGS1
IGC
India Globalization Capital Inc.
Menu
Home
IGC Pharma
Infrastructure Business
Investors
Press Releases
SEC Filings
XBRL Files
Leadership
Governance
IGC Files Patent for Hyalolex Formulation
April 10, 2018
September 10, 2019
by
charlie
Post navigation
← IGC Partners to Launch Hyalolex in Puerto Rico
IGC Radica Patente para la Fórmula Hyalolex →